Partnership Opportunities

Why the Oncolytic Virotherapy Summit?

The 6th OV Summit is the fastest route to in-depth discussions with organizations prioritizing oncolytic virus drug development. OV provides an unrivalled opportunity for your brand, your message and your reputation to be showcased in front of the leading minds of the growing ‘Oncology Virus Industry’. 

Who do I get to meet?

Gathering stakeholders and key opinion leaders, OV is the ultimate opportunity to position yourself as an expert in front of 100+ drug developers. Elevate your company’s standing and influence the future of oncolytic virus drug development. 

stats

Companies Who Have Joined Our Summit in the Past:

Pfizer_(2021)
AstraZeneca-Logo.wine
Takeda_logo_logotype
Janssen_Pharmaceuticals_logo.svg
Astellas_logo_logotype
Genentech.svg
Bristol-Myers_Squibb_logo_(2020).svg
1200px-Boehringer_Ingelheim_Logo.svg
amgen
1280px-Merck_Logo.svg
Bayer-Logo.wine
800px-AbbVie_logo.svg
192-1921487_bluebird-bio-bluebird-bio-inc-logo

What Can OV Do for You?

Boost your brand; Engage industry decision makers; Demonstrate thought leadership

We understand each business is different so we’ll work with you to build a bespoke partnership opportunity to fulfil your 2019/2020 business objectives. 

Previous partners have benefitted from: 

  • Panel participation 
  • Dedicated presentations 
  • Leading roundtable discussions 
  • Tailored branding 

How is OV Different? 

We will work with you to build bespoke partnerships to ensure you meet your 2021 business objectives. Get in touch today to learn more about how we can support you and your commercial goals within the field of Oncolytic viruses. 

Maximise your return on investment at the only conference to bring together industry and leaders to further the development of Oncolytic Virotherapies.